Medical Care Technologies Secures First Paid Deal for Health Software
New York, Wednesday, 14 October 2026.
Medical Care Technologies signed its first commercial artificial intelligence contract worth $250,000 on October 14, 2026, marking a critical transition from software development to direct corporate revenue.
Commercial AI Contract Secured
Medical Care Technologies Inc. (OTCID: MDCE) announced on October 14, 2026, that it has secured a multi-year software agreement valued at $250,000, including performance incentives [1]. This contract represents the company’s first direct monetization of custom AI software to an external enterprise client, distinct from their AI mobile app “Snapshot Recipes” [1]. The announcement marks a critical transition toward generating recurring AI software revenue and demonstrates commercial traction in healthcare technology integration [1].
Technical Evaluations and Metrics
Prior to this contract announcement, Medical Care Technologies published updated internal technical evaluation results for its MDCE Wound Monitoring application on October 12, 2026 [2][4]. The internal evaluation metrics cover three model layers under training, fulfilling a commitment made on October 7, 2026, to post results publicly [4]. These results are from controlled sequential smartphone captures and are not clinical study results or a claim of diagnostic performance [2].
Market Context and Future Outlook
The company identifies the chronic wound care market as exceeding $20 billion annually, with projections to surpass $30 billion by 2030 [4]. This projected increase represents a potential market growth rate of 50 percent over the period, driven by aging populations, diabetes, and late-intervention costs [4]. The company aims to pursue commercialization of its AI software, with subsequent model training cycles targeting improvements in everyday user-captured sequence acceptance rates [2].